NCT02839642View on ClinicalTrials.gov

Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy

PHASE3CompletedINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

July 26, 2016

Primary Completion Date

June 3, 2022

Study Completion Date

November 17, 2022

Conditions

Progressive Supranuclear Palsy (PSP)

Interventions

DRUG

Rivastigmine

DRUG

Placebo

Trial Locations (1)

13385

Service de Neurologie et Pathologie du Mouvement Hôpital de La Timone, Marseille

All Listed Sponsors

lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT02839642 - Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy | Biotech Hunter | Biotech Hunter